Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Illustration: Aïda Amer/Axios

The 14 million people who received a Johnson & Johnson shot are going to have to wait a few more weeks for answers on boosters due to lack of data, federal health officials said Wednesday.

Why it matters: The CDC currently advises people to stay with the shot they had initially. The effects of mixing doses are still unclear, but "it is anticipated that vaccine boosters will likely be needed," the White House tweeted.

  • Data for the J&J shot is months behind mRNA shots, since the company only received emergency use authorization in March while Pfizer and Moderna received theirs in December.
  • Still, emerging evidence shows people who received adenovirus vaccines like J&J or AstraZeneca would benefit from an additional dose of an mRNA vaccine.
  • Germany and the U.K. have been giving doses of mRNA vaccines to people who got the AstraZeneca vaccine, BBC reports.

What we know: Booster recommendations for J&J recipients were largely left out of the conversation last week when federal health officials announced that immunocompromised Americans can receive an additional dose of the COVID-19 vaccine.

  • J&J anticipates sharing data shortly regarding boosting with the Johnson & Johnson COVID-19 vaccine, a spokesperson tells Axios.
  • A July study from the company claims the shot provides adequate protection against the highly transmissible Delta variant. An independent one said protection decreased, however.

What's happening: The San Francisco health department was the first in the U.S. in early August to make an "accommodation" for J&J recipients to get a supplemental mRNA vaccine dose who have consulted with a doctor.

  • Clinicians have enough information to "provide J&J recipients guidance as to whether they should get a booster," Leana Wen, visiting professor at the George Washington University school of public health, said in a Washington Post op-ed.

What they're saying: It's unfortunate J&J recipients will eventually need a booster considering the single dose was enticing for some, but an mRNA shot is the next best step than getting another dose of the J&J, Phil Felgner, director of University of California, Irvine Vaccine Research and Development Center, tells Axios.

Yes, but: Willingness to get a booster is less prevalent among J&J recipients, a recent poll from Boston Children’s Hospital and the Harvard Medical School shows.

  • About two-thirds of those who received the Moderna or Pfizer vaccines want a booster, compared with 44% who received J&J.
  • 13% of J&J explicitly said they do not want a booster shot, more than two times as many Moderna and Pfizer recipients.

Go deeper

20 hours ago - World

Biden to push vaccine-sharing at UN, but boosters at home

Expand chart
Data: Our World in Data; Chart: Kavya Beheraj/Axios

President Biden will convene world leaders on Wednesday on the sidelines of the UN General Assembly to push them to do more to end the pandemic — though he's also facing criticism for prioritizing boosters at home.

Why it matters: There is still no functional plan in place to vaccinate the world, and past summits of this sort have flopped. The White House hopes that this virtual gathering will produce ambitious promises, accountability measures to track progress, and ultimately help achieve a 70% global vaccination rate this time next year.

Updated 4 hours ago - Politics & Policy

Coronavirus dashboard

Illustration: Aïda Amer/Axios

  1. Vaccines: Biden to get booster shot on camera — Pfizer vaccine safe, effective in children, company says — The booster vaccine discussion is far from over.
  2. Health: Study: Pandemic cut U.S. life expectancy by more than 9 million years — U.S. death toll surpasses 1918 flu fatalities — Chicago has highest case rates in city worker neighborhoods.
  3. Politics: Biden to push vaccine-sharing at UN, but boosters at home — Rep. Tim Ryan tests positive — Biden administration to lift travel ban for fully vaccinated international travelers.
  4. Education: D.C. schools to require teachers, staff to receive vaccine without testing option — More schools using "test-to-stay" strategy to minimize quarantines.
  5. Variant tracker: Where different strains are spreading.

D.C. schools to require teachers, staff to receive COVID vaccine without testing option

Photo: Bill O'Leary/The Washington Post via Getty Images

Washington D.C. Mayor Muriel Bowser (D) announced Monday that all teachers, school personnel and early child care workers must get vaccinated against the coronavirus by Nov. 1 with no option to opt out with weekly testing.

Why it matters: A majority of the D.C. city council urged Bowser to eliminate the weekly testing option for public school teachers and day care professionals, WashPost noted. Bowser's new mandate extended the vaccine requirement without a testing option to all D.C. public schools, charter schools, private schools and child care facilities.

You’ve caught up. Now what?

Sign up for Mike Allen’s daily Axios AM and PM newsletters to get smarter, faster on the news that matters.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!